Open Access
Open access

The research progress in the interaction between Candida albicans and cancers

Publication typeJournal Article
Publication date2022-09-28
scimago Q1
wos Q1
SJR1.172
CiteScore8.5
Impact factor4.5
ISSN1664302X
Microbiology (medical)
Microbiology
Abstract

Candida albicans is an opportunistic pathogenic fungus, which tends to infect the host with defective immune function including cancer patients. A growing number of studies have shown that C. albicans infection increases the host susceptibility to cancer such as oral, gastric, and colorectal cancer. Cancer and anti-cancer treatment may also affect the colonization of C. albicans. C. albicans may promote the development of cancer by damaging mucosal epithelium, inducing the production of carcinogens, triggering chronic inflammation including Th17 cell-mediated immune response. In this article, we aim to elaborate the interaction between C. albicans and cancers development and summarize the potential molecular mechanisms, so as to provide theoretical basis for prevention, diagnosis and treatment of cancers.

Found 
Found 

Top-30

Journals

1
2
3
Frontiers in Oncology
3 publications, 10%
Frontiers in Cellular and Infection Microbiology
2 publications, 6.67%
Clinical and Translational Oncology
1 publication, 3.33%
Microorganisms
1 publication, 3.33%
RSC Medicinal Chemistry
1 publication, 3.33%
Cancers
1 publication, 3.33%
Microbiology spectrum
1 publication, 3.33%
Polymer Bulletin
1 publication, 3.33%
Frontiers in Microbiology
1 publication, 3.33%
Journal of Infection
1 publication, 3.33%
Critical Reviews in Microbiology
1 publication, 3.33%
Biochemical Pharmacology
1 publication, 3.33%
mBio
1 publication, 3.33%
World Journal of Gastrointestinal Oncology
1 publication, 3.33%
Materials Chemistry and Physics
1 publication, 3.33%
Medicina
1 publication, 3.33%
Endocrine and Metabolic Science
1 publication, 3.33%
Gene
1 publication, 3.33%
Cancer Pathogenesis and Therapy
1 publication, 3.33%
Nutrients
1 publication, 3.33%
Molecular Cancer
1 publication, 3.33%
International Journal of Molecular Sciences
1 publication, 3.33%
Nature Microbiology
1 publication, 3.33%
Expert Review of Anti-Infective Therapy
1 publication, 3.33%
Medical Oncology
1 publication, 3.33%
Interdisciplinary Perspectives on Infectious Diseases
1 publication, 3.33%
1
2
3

Publishers

1
2
3
4
5
6
Springer Nature
6 publications, 20%
Frontiers Media S.A.
6 publications, 20%
Elsevier
6 publications, 20%
MDPI
5 publications, 16.67%
American Society for Microbiology
2 publications, 6.67%
Taylor & Francis
2 publications, 6.67%
Royal Society of Chemistry (RSC)
1 publication, 3.33%
Baishideng Publishing Group
1 publication, 3.33%
Hindawi Limited
1 publication, 3.33%
1
2
3
4
5
6
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
30
Share
Cite this
GOST |
Cite this
GOST Copy
Yu D., Liu Z. The research progress in the interaction between Candida albicans and cancers // Frontiers in Microbiology. 2022. Vol. 13.
GOST all authors (up to 50) Copy
Yu D., Liu Z. The research progress in the interaction between Candida albicans and cancers // Frontiers in Microbiology. 2022. Vol. 13.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3389/fmicb.2022.988734
UR - https://doi.org/10.3389/fmicb.2022.988734
TI - The research progress in the interaction between Candida albicans and cancers
T2 - Frontiers in Microbiology
AU - Yu, Dalang
AU - Liu, Zhiping
PY - 2022
DA - 2022/09/28
PB - Frontiers Media S.A.
VL - 13
PMID - 36246294
SN - 1664-302X
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Yu,
author = {Dalang Yu and Zhiping Liu},
title = {The research progress in the interaction between Candida albicans and cancers},
journal = {Frontiers in Microbiology},
year = {2022},
volume = {13},
publisher = {Frontiers Media S.A.},
month = {sep},
url = {https://doi.org/10.3389/fmicb.2022.988734},
doi = {10.3389/fmicb.2022.988734}
}